IBDEI1SI ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,28589,0)
 ;;=F16.159^^115^1408^7
 ;;^UTILITY(U,$J,358.3,28589,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28589,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,28589,1,4,0)
 ;;=4^F16.159
 ;;^UTILITY(U,$J,358.3,28589,2)
 ;;=^5003331
 ;;^UTILITY(U,$J,358.3,28590,0)
 ;;=F16.259^^115^1408^8
 ;;^UTILITY(U,$J,358.3,28590,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28590,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/ Mod/Sev Use D/O
 ;;^UTILITY(U,$J,358.3,28590,1,4,0)
 ;;=4^F16.259
 ;;^UTILITY(U,$J,358.3,28590,2)
 ;;=^5003344
 ;;^UTILITY(U,$J,358.3,28591,0)
 ;;=F16.959^^115^1408^9
 ;;^UTILITY(U,$J,358.3,28591,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28591,1,3,0)
 ;;=3^Hallucinogen Induced Psychotic D/O w/o Use D/O
 ;;^UTILITY(U,$J,358.3,28591,1,4,0)
 ;;=4^F16.959
 ;;^UTILITY(U,$J,358.3,28591,2)
 ;;=^5003356
 ;;^UTILITY(U,$J,358.3,28592,0)
 ;;=F16.99^^115^1408^17
 ;;^UTILITY(U,$J,358.3,28592,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28592,1,3,0)
 ;;=3^Hallucinogen Related D/O,Unspec
 ;;^UTILITY(U,$J,358.3,28592,1,4,0)
 ;;=4^F16.99
 ;;^UTILITY(U,$J,358.3,28592,2)
 ;;=^5133359
 ;;^UTILITY(U,$J,358.3,28593,0)
 ;;=F16.983^^115^1408^16
 ;;^UTILITY(U,$J,358.3,28593,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28593,1,3,0)
 ;;=3^Hallucinogen Persisting Perception D/O
 ;;^UTILITY(U,$J,358.3,28593,1,4,0)
 ;;=4^F16.983
 ;;^UTILITY(U,$J,358.3,28593,2)
 ;;=^5003358
 ;;^UTILITY(U,$J,358.3,28594,0)
 ;;=F16.21^^115^1408^20
 ;;^UTILITY(U,$J,358.3,28594,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28594,1,3,0)
 ;;=3^Hallucinogen Use DO,Mod/Sev,In Remiss
 ;;^UTILITY(U,$J,358.3,28594,1,4,0)
 ;;=4^F16.21
 ;;^UTILITY(U,$J,358.3,28594,2)
 ;;=^5003337
 ;;^UTILITY(U,$J,358.3,28595,0)
 ;;=F16.11^^115^1408^18
 ;;^UTILITY(U,$J,358.3,28595,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28595,1,3,0)
 ;;=3^Hallucinogen Use DO,Mild,In Remiss
 ;;^UTILITY(U,$J,358.3,28595,1,4,0)
 ;;=4^F16.11
 ;;^UTILITY(U,$J,358.3,28595,2)
 ;;=^268239
 ;;^UTILITY(U,$J,358.3,28596,0)
 ;;=F11.10^^115^1409^25
 ;;^UTILITY(U,$J,358.3,28596,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28596,1,3,0)
 ;;=3^Opioid Use DO,Mild,Uncomp
 ;;^UTILITY(U,$J,358.3,28596,1,4,0)
 ;;=4^F11.10
 ;;^UTILITY(U,$J,358.3,28596,2)
 ;;=^5003114
 ;;^UTILITY(U,$J,358.3,28597,0)
 ;;=F11.129^^115^1409^22
 ;;^UTILITY(U,$J,358.3,28597,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28597,1,3,0)
 ;;=3^Opioid Intox w/o Perceptual Dists w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,28597,1,4,0)
 ;;=4^F11.129
 ;;^UTILITY(U,$J,358.3,28597,2)
 ;;=^5003118
 ;;^UTILITY(U,$J,358.3,28598,0)
 ;;=F11.14^^115^1409^5
 ;;^UTILITY(U,$J,358.3,28598,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28598,1,3,0)
 ;;=3^Opioid Induced Depressive D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,28598,1,4,0)
 ;;=4^F11.14
 ;;^UTILITY(U,$J,358.3,28598,2)
 ;;=^5003119
 ;;^UTILITY(U,$J,358.3,28599,0)
 ;;=F11.182^^115^1409^11
 ;;^UTILITY(U,$J,358.3,28599,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28599,1,3,0)
 ;;=3^Opioid Induced Sleep D/O w/ Mild Use D/O
 ;;^UTILITY(U,$J,358.3,28599,1,4,0)
 ;;=4^F11.182
 ;;^UTILITY(U,$J,358.3,28599,2)
 ;;=^5003124
 ;;^UTILITY(U,$J,358.3,28600,0)
 ;;=F11.20^^115^1409^28
 ;;^UTILITY(U,$J,358.3,28600,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,28600,1,3,0)
 ;;=3^Opioid Use DO,Mod/Sev,Uncomp
 ;;^UTILITY(U,$J,358.3,28600,1,4,0)
 ;;=4^F11.20
